Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Malignant Neoplasm in the Chest Wall|Recurrent Breast Carcinoma
Interventions: DRUG: Olaparib|PROCEDURE: Hyperthermia Treatment|OTHER: Questionnaire Administration|OTHER: Quality-of-Life Assessment
Sponsor: Thomas Jefferson University
Collaborators: AstraZeneca